openPR Logo
Press release

Erythropoietin Drugs Market 2023 Update - Projected Revenue Surges to USD 14.41 Billion by 2028, Boasting a 5.7% Compound Annual Growth Rate (CAGR)

12-21-2023 07:48 AM CET | Health & Medicine

Press release from: allied market research

/ PR Agency: allied market research
Erythropoietin Drugs Market 2023 Update - Projected Revenue

Erythropoietin Drugs Market Statistics: The global Erythropoietin Drugs Market was pegged at $9.24 billion in 2020, and is estimated to reach $14.41 billion by 2028, growing at a CAGR of 5.7% from 2021 to 2028.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/59

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก: The growth of the market is driven by factors such as the increasing prevalence of chronic kidney diseases, the rise in the number of cancer patients undergoing chemotherapy, and the growing geriatric population.

๐“๐ฒ๐ฉ๐ž๐ฌ ๐จ๐Ÿ ๐ž๐ซ๐ฒ๐ญ๐ก๐ซ๐จ๐ฉ๐จ๐ข๐ž๐ญ๐ข๐ง ๐๐ซ๐ฎ๐ ๐ฌ: The two major types of erythropoietin drugs are biosimilars and biologics. Biosimilars are expected to dominate the market due to their cost-effectiveness compared to biologics.

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐š๐ซ๐ž๐š๐ฌ: Erythropoietin drugs are primarily used in the treatment of anemia caused by chronic kidney disease, cancer, and other diseases. They are also used to reduce the need for blood transfusions during surgeries.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ: North America held the largest share of the market in 2020, followed by Europe and Asia Pacific. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.


๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

On the basis product type, epoetin-alfa segment is anticipated to grow with the highest revenue throughout the forecast period, owing to increase in sales of Epogen, which is the top selling brand of erythropoietin, developed by Amgen. Epogen indicated notable growth in the U.S. market as Amgen procured patent protection for this product.

By application, the kidney disorders (ESRD and Dialysis) segment accounted for a major share in 2020, and is expected to exhibit a prominent growth rate during the forecast period, owing to increase in cases of patients with kidney disease. Furthermore, ESRD is majorly responsible for prescription of EPO treatment among renal disease patients.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง -
https://www.alliedmarketresearch.com/request-for-customization/59

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:

AMGEN INC.
JOHNSON AND JOHNSON
ROCHE DIAGNOSTICS
HOSPIRA INC.
LG LIFE SCIENCES LTD.
BIOCON
INTAS PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES LTD.
RANBAXY LABORATORIES LTD.
CELLTRION, INC

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/checkout-final/fbeb76f67944772a3785fb1c960404e6

๐•๐€๐‹๐”๐„ ๐๐‘๐Ž๐๐Ž๐’๐ˆ๐“๐ˆ๐Ž๐๐’ ๐‘๐„๐‹๐€๐“๐„๐ƒ ๐“๐Ž ๐“๐‡๐„ ๐‘๐„๐๐Ž๐‘๐“:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Browse more latest healthcare reports:

๐“๐จ๐ฉ๐ข๐œ๐š๐ฅ ๐Ž๐ฑ๐ฒ๐ ๐ž๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.alliedmarketresearch.com/topical-oxygen-therapy-market-A16966

๐‡๐ž๐ฆ๐จ๐ฌ๐ญ๐š๐ญ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.alliedmarketresearch.com/hemostats-market-A16840

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐จ๐ง ๐€๐ง๐ข๐ฆ๐š๐ฅ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.alliedmarketresearch.com/companion-animal-diagnostics-market-A11127

๐‘๐š๐๐ข๐จ๐ฌ๐ฎ๐ซ๐ ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.alliedmarketresearch.com/radiosurgery-systems-market-A14841

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erythropoietin Drugs Market 2023 Update - Projected Revenue Surges to USD 14.41 Billion by 2028, Boasting a 5.7% Compound Annual Growth Rate (CAGR) here

News-ID: 3334610 • Views: โ€ฆ

More Releases from allied market research

Cables Market Size to Reach $156.5 Billion by 2030
Cables Market Size to Reach $156.5 Billion by 2030
The global cables market share is expected to witness considerable growth, owing to increase in demand for cables in Internet of Things solutions, especially in Asia-Pacific and Eur0pe, due to rise in demand for digital infrastructure solution in these regions. According to a new report published by Allied Market Research, titled, "Cables Market by Installation Type, Voltage Type, End Use: Global Opportunity Analysis and Industry Forecast, 2020-2030," the global cables marketโ€ฆ
Amphibious Vehicle Market Share is to Reach $5.02 Billion by 2027
Amphibious Vehicle Market Share is to Reach $5.02 Billion by 2027
By end use, the commercial segment dominated the global amphibious vehicle market in 2019, in terms of revenue, and the defense segment is anticipated to witness highest CAGR of 9.7% during the forecast period. By mode of propulsion, the track-based segment incurs the higher share. Presently, North America is the highest revenue contributor, and LAMEA is expected to lead the market during the forecast period, followed by Asia-Pacific According to aโ€ฆ
Very Light Jet Market Size is to Reach $10.44 Billion by 2030
Very Light Jet Market Size is to Reach $10.44 Billion by 2030
By aircraft type, the light aircraft segment dominated the global market in 2020 in terms of revenue. However, the ultra-light aircraft segment is expected to lead the market during the forecast period. Depending on material, the composites segment incurs a higher share. North America was the highest revenue contributor in 2020. However, Asia-Pacific is anticipated to lead the market growth by 2030. According to a recent report published by Allied Marketโ€ฆ
IoT Sensors Market Size to Reach $141.80 Billion By 2030
IoT Sensors Market Size to Reach $141.80 Billion By 2030
The IoT sensors market is expected to grow at a significant rate during the forecast period, owing to growth in use of IoT sensors in automotive and industrial sectors and high demand for connected and wearable devices. Moreover, surge in demand for IoT sensors in development of smart cities notably contribute toward growth of the IoT sensors market According to a new report published by Allied Market Research, titled, "IoT Sensorsโ€ฆ

All 5 Releases


More Releases for Erythropoietin

Erythropoietin (EPO) Drugs Market: An Overview
Introduction: Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing theโ€ฆ
Erythropoietin Drugs Market Size, Opportunities 2022-2030
The Erythropoietin Drugs Market. The report delves into current trends, growth drivers, competitive landscape, and future forecasts, providing invaluable insights for stakeholders looking to understand the dynamics of this rapidly evolving sector. The global erythropoietin drugs market is poised for substantial growth, and the insights provided in this report are crucial for navigating this promising landscape. ------------------------------------------------------------------------------------------------------------------- REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2675 ------------------------------------------------------------------------------------------------------------------- Market Overview: The global erythropoietin drugs market wasโ€ฆ
Erythropoietin Drugs Market - Revitalizing Lives: Erythropoietin Drugs for Enhan โ€ฆ
Newark, New Castle, USA: The "Erythropoietin Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Erythropoietin Drugs Market: https://www.growthplusreports.com/report/erythropoietin-drugs-market/8627 This latest report researches the industry structure, sales, revenue,โ€ฆ
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Click to view theโ€ฆ
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms ofโ€ฆ
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports. Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development ofโ€ฆ